Neuroscience Center of Excellence Act of 2021

HR 7666, Restoring Hope for Mental Health & Well Being Act of 2022; S. 4170, Mental Health Reform Reauthorization Act of 2022; H.R. 7232, 9-8-8 and Parity Assistance Act of 2022; HR 6000, Cures 2.0 Act; S.3427, the Neuroscience Center of Excellence Act of 2021; HR 5801, HELP Copays Act; Mental Health Reform Act reauthorization; H.R. 5376, Inflation Reduction Act of 2022 (provisions related to pharmaceuticals); issues relating to diversity in clinical trials, agitation in Alzheimers disease, chronic kidney disease and early detection, PTSD, and mental health as a chronic condition.

Client expense: $350,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 Mental Health - H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 Fiscal Year 2023 Military Construction, Veterans Affairs, and Related Agencies Funding Bill Fiscal Year 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Funding H.R.2617 - Consolidated Appropriations Act, 2023

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN (Bringing Regulatory Advances Into Neuroscience Act of 2021 H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act (PACTPA) H.R. 3967 / S. 3373 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities. H.R. 8585/S. 4851, the National Plan to End Parkinson's Act - to require the U.S. Department of Health and Human Services (HHS) to carry out a project to prevent and cure Parkinson's disease. Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent and cure the disease; (2) improve diagnosis, treatment, and care of those with the disease; and (3) address health and other disparities related to the disease. HHS must also conduct annual assessments on the preparation for and response to the increased burden of Parkinson's disease. In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and cure of Parkinson's disease. Establishing Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and to allow researchers to gather more data to study the progression of Parkinson's among people living with the disease. Expanding access to health care for people living with Parkinson's via telehealth by removing Medicare telehealth geographic and originating site restrictions, extending coverage and reimbursement for health care providers who bill Medicare for providing services via telehealth (including seeing new patients and audio-only telehealth for clinically appropriate services/visits), ensuring payment parity for telehealth and in-person services, and removing Medicare in-person requirements for accessing mental health services via telehealth. H.R. 2617, the Consolidated Appropriations Act, 2023 Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 S. 464/H.R. 2163, the Safe Step Act - to amend the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol to enable people living with Parkinsons disease to access the medications they need to best manage their disease S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN (Bringing Regulatory Advances Into Neuroscience) Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT (Diverse and Equitable Participation in Clinical Trials) Act S. 331, ABLE (Achieving a Better Life Experience) Age Adjustment Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 4170, Mental Health Reform Reauthorization Act of 2022; H.R. 7232, 9-8-8 and Parity Assistance Act of 2022; HR 6000, Cures 2.0 Act; S.3427, the Neuroscience Center of Excellence Act of 2021; HR 5801, HELP Copays Act; Mental Health Reform Act reauthorization; H.R. 5376, Inflation Reduction Act of 2022 (provisions related to pharmaceuticals); issues relating to diversity in clinical trials, agitation in Alzheimers disease, chronic kidney disease and early detection, PTSD, and mental health as a chronic condition.

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-H.R. 5376 Inflation Reduction Act, support addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; and barring the use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation. -S. 464/H.R. 2163, Safe Step Act, support passage. -HR 8454 Medical Marijuana and Cannabidiol Research Expansion Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations. -S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 / H.R. 7667 Food and Drug Amendments Act of 2022, ensure that any new regulation of dietary supplements protects access to CBD, support amendment to ban use of certain electric shock devices, support provisions regarding diverse enrollment in clinical trials, support provisions to support orphan drug development

Client expense: $65,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act FDA Reform - H.R.5435 - BRAIN Act of 2021 FDA Reform- H.R.7667 - Food and Drug Amendments of 2022 FDA Reform- S. 4348 FDASLA Act of 2022 Mental Health - H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 Fiscal Year 2023 Military Construction, Veterans Affairs, and Related Agencies Funding Bill Fiscal Year 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Funding

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1219/S.331, ABLE Age Adjustment Act, related to amending the Internal Revenue Code of 1986 to increase the age requirement with respect to eligibility for qualified ABLE programs. H.R. 1235/S.3301, The Charlotte Woodward Organ Transplant Discrimination Prevention Act, related to prohibiting discrimination on the basis of mental or physical disability in cases of anatomical gifts and organ transplants H.R. 2373 / S.260, the Transformation to Competitive Integrated Employment Act, related to assisting employers providing employment under special certificates issued under section 14(c) of the Fair Labor Standards Act of 1938 in transforming their business and program models to models that support individuals with disabilities through competitive integrated employment, to phase out the use of such special certificates, and for other purposes. H.R. 4672, the ABLE Employment Flexibility Act, related to amending the Internal Revenue Code to allow employers to contribute to ABLE accounts in lieu of retirement plan contributions. H.R.6205 / S. 3360, EDUCATORS for America Act, relating to reauthorizing title II of the Higher Education Act of 1965, and for other purposes. H.R. 7309, the Workforce Innovation and Opportunity Act of 2022 - related to reauthorizing the Workforce Innovation and Opportunity Act. H.R. 7775 / S.4203, the NAPA Reauthorization Act - related to extending the National Alzheimers Project Act. S.3427, the Neuroscience Center of Excellence Act - related to authorizing the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence. A bill not yet introduced to amend the Individuals with Disabilities Education Act (P.L. 89-10); and A bill not yet introduced to amend the Higher Education Act (P.L. 89-329). Implementation of the Fair Labor Standards Act of 1938 (P.L. 75-718); Implementation of the Individuals with Disabilities Education Act (P.L. 89-110); Implementation of the National Alzheimers Project Act (P.L. 107-279); and Implementation of the Social Security Amendments of 1965 (Public Law 89-97), as amended.

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN Act H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act H.R. 3967 / S. 3373 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $31,190 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577, A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331, ABLE Age Adjustment Act H.R. 5376, the Inflation Reduction Act of 2022 H.R. 8585/S. 4851, the National Plan to End Parkinson's Act

Client expense: $31,190 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

H.R.761, Marriage Access for People with Special Abilities (MAPSA) Act, related to amending amend title XVI of the Social Security Act to provide that the supplemental security income benefits of adults with intellectual or developmental disabilities shall not be reduced by reason of marriage. H.R. 1219/S.331, ABLE Age Adjustment Act, related to amending the Internal Revenue Code of 1986 to increase the age requirement with respect to eligibility for qualified ABLE programs. H.R. 1235/S.3301, The Charlotte Woodward Organ Transplant Discrimination Prevention Act, related to prohibiting discrimination on the basis of mental or physical disability in cases of anatomical gifts and organ transplants H.R. 2373 / S.260, the Transformation to Competitive Integrated Employment Act, related to assisting employers providing employment under special certificates issued under section 14(c) of the Fair Labor Standards Act of 1938 in transforming their business and program models to models that support individuals with disabilities through competitive integrated employment, to phase out the use of such special certificates, and for other purposes. H.R. 3474 / S.1858, the Keeping All Students Safe Act, related to prohibiting and preventing seclusion, mechanical restraint, chemical restraint, and dangerous restraints that restrict breathing, and to prevent and reduce the use of physical restraint in schools, and for other purposes. H.R. 3836 / S.2029, the Protecting our Students in Schools Act, related to prohibiting the use of corporal punishment in schools, and for other purposes. H.R. 4672, the ABLE Employment Flexibility Act, related to amending the Internal Revenue Code to allow employers to contribute to ABLE accounts in lieu of retirement plan contributions. H.R.6205 / S. 3360, EDUCATORS for America Act, relating to reauthorizing title II of the Higher Education Act of 1965, and for other purposes. H.R. 7309, the Workforce Innovation and Opportunity Act of 2022 - related to reauthorizing the Workforce Innovation and Opportunity Act. S.3427, the Neuroscience Center of Excellence Act - related to authorizing the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence. A bill not yet introduced to amend the Individuals with Disabilities Education Act (P.L. 89-10); A bill not yet introduced to amend the Higher Education Act (P.L. 89-329); A bill not yet introduced to reauthorize the Education Sciences Reform Act (P.L. 107-279); and A bill not yet introduced to reauthorize the National Alzheimers Project Act (P.L. 111-375). Implementation of the Fair Labor Standards Act of 1938 (P.L. 75-718); Implementation of the Individuals with Disabilities Education Act (P.L. 89-110); Implementation of the National Alzheimers Project Act (P.L. 107-279); and Implementation of the Social Security Amendments of 1965 (Public Law 89-97), as amended.

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $450,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees

Client expense: $270,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Reconciliation legislation, support additional funding for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; expand Medicaid. -S. 3799 PREVENT Pandemics Act, incorporate disability into pandemic preparedness legislation Work has stalled on this, we had success in committee but havent done much on it since we could take it out -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and H.R. 5657, Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations. - S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 / H.R. 7667 Food and Drug Amendments Act of 2022, ensure that any new regulation of dietary supplements protects access to CBD, support amendment to ban use of certain electric shock devices, support provisions regarding diverse enrollment in clinical trials, support provisions to support orphan drug development

Client expense: $65,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2938, Bipartisan Safer Communities Act; S. 4170, Mental Health Reform Reauthorization Act of 2022; H.R. 7232, 9-8-8 and Parity Assistance Act of 2022; HR 6000, Cures 2.0 Act; S.3427, the Neuroscience Center of Excellence Act of 2021; HR 5801, HELP Copays Act; Mental Health Reform Act reauthorization; H.R. 5376, Reconciliation Build Back Better Act (provisions related to pharmaceuticals); issues relating to diversity in clinical trials, agitation in Alzheimers disease, chronic kidney disease and early detection, PTSD, and mental health as a chronic condition.

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act FDA Reform - H.R.5435 - BRAIN Act of 2021 FDA Reform- H.R.7667 - Food and Drug Amendments of 2022 FDA Reform- S. 4348 FDASLA Act of 2022 Patient Access - H.R.5801 - HELP Copays Act Mental Health - H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN Act H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act H.R. 3967 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $61,153 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253, the Cannabidiol and Marihuana Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577: A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331: ABLE Age Adjustment Act

Client expense: $61,153 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

The Charlotte Woodward Organ Transplant Discrimination Prevention Act (H.R. 1235 / S. 3301) Neuroscience Center of Excellence Act (S. 3427) Funding for INCLUDE project at NIH Cures 2.0 Act (H.R. 6000) General advocacy for Alzheimers including increasing research dollars and ensuring proper payment and access to treatments.

Client expense: Not reported · Firm income: Not reported

The Charlotte Woodward Organ Transplant Discrimination Prevention Act (H.R. 1235 / S. 3301) Neuroscience Center of Excellence Act (S. 3427) Funding for INCLUDE project at NIH Cures 2.0 Act (H.R. 6000) General advocacy for Alzheimers including increasing research dollars and ensuring proper payment and access to treatments.

Client expense: Not reported · Firm income: Not reported

The Charlotte Woodward Organ Transplant Discrimination Prevention Act (H.R. 1235 / S. 3301) Neuroscience Center of Excellence Act (S. 3427) Funding for INCLUDE project at NIH Cures 2.0 Act (H.R. 6000) General advocacy for Alzheimers including increasing research dollars and ensuring proper payment and access to treatments.

Client expense: Not reported · Firm income: Not reported

S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-Build Back Better Act or similar legislation, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; add vision, dental, and hearing coverage to Medicare; expand Medicaid. -S. 3799 PREVENT Pandemics Act, incorporate disability into pandemic preparedness legislation. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and H.R. 5657, Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 7232, 9-8-8 and Parity Assistance Act of 2022; HR 6000, Cures 2.0 Act; S.3427, the Neuroscience Center of Excellence Act of 2021; HR 5801, HELP Copays Act; Mental Health Reform Act reauthorization; H.R. 5376, Reconciliation Build Back Better Act (provisions related to pharmaceuticals); issues relating to diversity in clinical trials, agitation in alzheimers disease, chronic kidney disease and early detection, PTSD, and mental health as a chronic condition.

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021

Client expense: $400,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PDUFA VII; S 3427 FDA NCOE Authorization

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act FDA Reform - H.R.5435 - BRAIN Act of 2021 Issues pertaining to the Prescription Drug User Fee Act Issues pertaining to Accelerated Approval of drugs

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth Advocating for rulemaking to ensure standards in the Americans with Disabilities Act (ADA) are applied to the internet Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253, the Cannabidiol and Marihuana Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577: A resolution designating April 2022 as "Parkinson's Awareness Month"

Client expense: $57,949 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN Act H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act H.R. 3967 Honoring our Promise to Address Comprehensive Toxics (PACT) Act

Client expense: $57,949 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 447, National Apprenticeship Act, related to amending the Act of August 16, 1937 (commonly referred to as the National Apprenticeship Act) and expanding the national apprenticeship system to include apprenticeships, youth apprenticeships, and pre-apprenticeship registered under such Act, promoting the furtherance of labor standards necessary to safeguard the welfare of apprentices, and for other purposes. H.R.761, Marriage Access for People with Special Abilities (MAPSA) Act, related to amending amend title XVI of the Social Security Act to provide that the supplemental security income benefits of adults with intellectual or developmental disabilities shall not be reduced by reason of marriage. H.R. 1219/S.331, ABLE Age Adjustment Act, related to amending the Internal Revenue Code of 1986 to increase the age requirement with respect to eligibility for qualified ABLE programs. H.R. 1235/S.3301, The Charlotte Woodward Organ Transplant Discrimination Prevention Act, related to prohibiting discrimination on the basis of mental or physical disability in cases of anatomical gifts and organ transplants H.R. 2373 / S.260, the Transformation to Competitive Integrated Employment Act, related to assisting employers providing employment under special certificates issued under section 14(c) of the Fair Labor Standards Act of 1938 in transforming their business and program models to models that support individuals with disabilities through competitive integrated employment, to phase out the use of such special certificates, and for other purposes. H.R. 3474 / S.1858, the Keeping All Students Safe Act, related to prohibiting and preventing seclusion, mechanical restraint, chemical restraint, and dangerous restraints that restrict breathing, and to prevent and reduce the use of physical restraint in schools, and for other purposes. H.R. 3836 / S.2029, the Protecting our Students in Schools Act, related to prohibiting the use of corporal punishment in schools, and for other purposes. H.R. 4672, the ABLE Employment Flexibility Act, related to amending the Internal Revenue Code to allow employers to contribute to ABLE accounts in lieu of retirement plan contributions. H.R. 4756 / S.2504, the Exercise and Fitness for All Act of 2021, related to promoting the provision of exercise or fitness equipment, and exercise or fitness classes and instruction, that are accessible to individuals with disabilities. H.R.6205 / S. 3360, EDUCATORS for America Act, relating to reauthorizing title II of the Higher Education Act of 1965, and for other purposes. H.R. 6783, the Autism Family Caregivers act - related to authorizing the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to award grants for providing evidence-based caregiver skills training to caregivers of children with autism spectrum disorder or other developmental disabilities or delays, and for other purposes. H.R. 7309, the Workforce Innovation and Opportunity Act of 2022 - related to reauthorizing the Workforce Innovation and Opportunity Act. S.3427, the Neuroscience Center of Excellence Act - related to authorizing the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence. A bill not yet introduced to amend the Individuals with Disabilities Education Act (P.L. 89-10); A bill not yet introduced to amend the Higher Education Act (P.L. 89-329); A bill not yet introduced to reauthorize the Education Sciences Reform Act (P.L. 107-279); A bill not yet introduced to reauthorize the National Alzheimers Project Act (P.L. 111-375); and A bill not yet introduced to prohibit discrimination against individuals with disabilities who need long-term services and supports, and for other purposes. Implementation of the Fair Labor Standards Act of 1938 (P.L. 75-718); Implementation of the Individuals with Disabilities Education Act (P.L. 89-110); and Implementation of the National Alzheimers Project Act (P.L. 107-279).

Client expense: $20,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

H.R. 1235/S.3301, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 2373/S.3238, Transformation to Competitive Integrated Employment Act, all provisions H.R. 4160, Global Autism Act, all provisions H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, provisions related to the Autism Care Demonstration program H.R. 4432, Department of Defense Appropriations Act, 2022, provisions related to congressionally directed medical research programs H.R. 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, and the Health Resources and Services Administration H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022, provisions related to Kevin and Avonte's Law H.R. 5551, Improving the Health of Children Act, provisions related to reauthorization of the National Center on Birth Defects and Developmental Disabilities H.R. 5376, Build Back Better Act, provisions related to home and community-based services, competitive integrated employment, caregiver workforce, immigration, and paid family and medical leave H.R. 5989, Precision Medicine Answers for Kids Today Act, all provisions H.R. 6000, Cures 2.0 Act, provisions related to educational programs and training for caregivers, expanding access to genetic testing, establishment of additional inter-center institutes at the Food and Drug Administration, and establishment of an Advanced Research Projects Agency for Health (ARPA-H) S.3427, Neuroscience Center of Excellence Act of 2021, all provisions Implementation of Public Law No. 114-255, 21st Century Cures Act, provisions related to electronic visit verification Implementation of Public Law No. 116-60, Autism Collaboration, Research, Education, and Support Act of 2019, all provisions Implementation of Public Law No. 116-260, Consolidated Appropriations Act, 2021, provisions related to eliminating barriers to the training and employment of people with disabilities Implementation of Public Law No. 117-2, American Rescue Plan Act of 2021, provisions related to home and community-based services A bill not yet introduced in the Senate making appropriation for Fiscal Year 2022 for the Departments of Labor, Health and Human Services, and Education, and related agencies, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, and the Health Resources and Services Administration A bill not yet introduced to create a caregiver skills training demonstration program

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Labor, Dept of (DOL), Natl Institute of Mental Health (NIMH), SENATE

Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6000, Cures 2.0 Act; S.3427, the Neuroscience Center of Excellence Act of 2021; HR 5801, HELP Copays Act; Mental Health Reform Act reauthorization; H.R. 5376, Reconciliation Build Back Better Act (provisions related to pharmaceuticals); and issues relating to diversity in clinical trials, agitation in alzheimers disease, chronic kidney disease and early detection, mental health, and PTSD.

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 586/ S. 1391 - STANDUP Act of 2021 H.R. 654 - Drug-Free Communities Pandemic Relief Act H.R. 925 - Data to Save Moms Act H.R. 1475/ S.1795 - Pursuing Equity in Mental Health Act H.R. 1667 / S.610 - Lorna Breen Health Care Provider Protection Act H.R. 2051 - Methamphetamine Response Act of 2021 H.R. 2163 / S. 464 - Safe Step Act H.R. 2255/ S. 1024 - Healthcare Workforce Resilience Act H.R. 2256/ S. 834 -Resident Physician Shortage Reduction Act H.R. 2364 - Synthetic Opioid Danger Awareness Act H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 H.R. 2503 - Social Determinants Accelerator Act of 2021 H.R. 3173/ S. 3018 - Improving Seniors' Timely Access to Care Act H.R 3441/S. 1438 - Substance Use Disorder Workforce Act/ Opioid Workforce Act H.R. 3407/ S. 411 - MOMMAs Act H.R. 3447 - Permanency for Audio-Only Telehealth Act H.R. 3541/ S. 1810 - Conrad State 30 and Physician Access Reauthorization Act H.R. 3753/S. 1962 - Parity Implementation Assistance Act H.R. 3894 - Collecting and Analyzing Resources Integral and Necessary for Guidance (CARING) for Social Determinants Act of 2021 H.R. 4026 - Social Determinants of Health Data Analysis Act of 2021 H.R. 4058/S. 2061 - Telemental Health Care Access Act H.R. 4194 - People's Response Act H.R. 4387 - Maternal Health Quality Improvement Act of 2021 H.R. 4406 - Supporting Medicaid in the U.S. Territories Act of 2021 H.R. 4770 - Evaluating Disparities and Outcomes of Telehealth (EDOT) Act of 2021 H.R. 4943 - Childrens Mental Health Infrastructure Act of 2021 H.R. 4944 - Helping Kids Cope Act of 2021 HR 5218 - Collaborate in an Orderly and Cohesive Manner Act H.R. 5235 - Student Mental Health Helpline Act of 2021 H.R. 5407 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act H.R. 5435/ S. 3427 - BRAIN Act of 2021/Neuroscience Center of Excellence Act of 2021 H.R. 5611/ S.1902 - Behavioral Health Crisis Services Expansion Act H.R. 5674/ S. 3061 - Medicare Mental Health Inpatient Equity Act H.R. 5837 - A bill to expand telehealth services relating to substance use disorder H.R.5950 - Improving Patient Access to Care and Treatment Act H.R. 6000 - Cures 2.0 Act H.R. 6020/ S. 3314 - Supporting Medicare Providers Act of 2021 H.R. 6202 - Telehealth Extension Act of 2021 S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act (No legislation) Implementation of No Surprises Act

Client expense: $83,505 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S.3427 Neuroscience Center of Excellence Act. H.R.5435 The BRAIN Act H.R.6000 Cures 2.0

Client expense: $49,562 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act Patient Access - H.R.5801 - HELP Copays Act Issues pertaining to the creation of a Neuroscience Center of Excellence at FDA

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1235/S.3301, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 2373/S.3238, Transformation to Competitive Integrated Employment Act, all provisions H.R. 4160, Global Autism Act, all provisions H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, provisions related to the Autism Care Demonstration program H.R. 4432, Department of Defense Appropriations Act, 2022, provisions related to congressionally directed medical research programs H.R. 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, and the Health Resources and Services Administration H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022, provisions related to Kevin and Avonte's Law H.R. 5551, Improving the Health of Children Act, provisions related to reauthorization of the National Center on Birth Defects and Developmental Disabilities H.R. 5376, Build Back Better Act, provisions related to home and community-based services, competitive integrated employment, caregiver workforce, immigration, and paid family and medical leave H.R. 5989, Precision Medicine Answers for Kids Today Act, all provisions H.R. 6000, Cures 2.0 Act, provisions related to educational programs and training for caregivers, expanding access to genetic testing, establishment of additional inter-center institutes at the Food and Drug Administration, and establishment of an Advanced Research Projects Agency for Health (ARPA-H) S.3427, Neuroscience Center of Excellence Act of 2021, all provisions Implementation of Public Law No. 114-255, 21st Century Cures Act, provisions related to electronic visit verification Implementation of Public Law No. 116-60, Autism Collaboration, Research, Education, and Support Act of 2019, all provisions Implementation of Public Law No. 116-260, Consolidated Appropriations Act, 2021, provisions related to eliminating barriers to the training and employment of people with disabilities Implementation of Public Law No. 117-2, American Rescue Plan Act of 2021, provisions related to home and community-based services A bill not yet introduced in the Senate making appropriation for Fiscal Year 2022 for the Departments of Labor, Health and Human Services, and Education, and related agencies, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, and the Health Resources and Services Administration A bill not yet introduced to create a caregiver skills training demonstration program

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Labor, Dept of (DOL), Natl Institute of Mental Health (NIMH), SENATE